T1	p 25 43	prostatic cancer .
T2	p 162 222	previously untreated patients with prostatic cancer in order
T3	p 623 677	patients with advanced disease no longer responsive to
T4	i 238 317	dose Stilboestrol versus Cyproterone acetate versus Medroxyprogesterone acetate
T5	i 723 751	Adriamycin or Procarbazine .
T6	o 752 776	Toxicity and early death